The stock of CVS Health Corp (NYSE: CVS) has decreased by -7.57 when compared to last closing price of 63.67. Despite this, the company has experienced a -11.68% fall in its stock price over the last five trading sessions. schaeffersresearch.com reported 2024-10-18 that CVS Health Corp (NYSE:CVS) stock is down 7.3% at $59.04 at last glance, after news that the company has replaced CEO Karen Lynch with pharmacy benefits executive David Joyner.
Is It Worth Investing in CVS Health Corp (NYSE: CVS) Right Now?
CVS Health Corp (NYSE: CVS) has a higher price-to-earnings ratio of 10.47x compared to its average ratio. CVS has 36-month beta value of 0.53. Analysts have mixed views on the stock, with 10 analysts rating it as a “buy,” 5 as “overweight,” 9 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CVS is 1.26B, and currently, short sellers hold a 1.57% ratio of that float. The average trading volume of CVS on October 18, 2024 was 9.66M shares.
CVS’s Market Performance
The stock of CVS Health Corp (CVS) has seen a -11.68% decrease in the past week, with a 0.77% rise in the past month, and a 0.89% gain in the past quarter. The volatility ratio for the week is 2.34%, and the volatility levels for the past 30 days are at 2.30% for CVS. The simple moving average for the past 20 days is -6.55% for CVS’s stock, with a -9.98% simple moving average for the past 200 days.
Analysts’ Opinion of CVS
Many brokerage firms have already submitted their reports for CVS stocks, with Barclays repeating the rating for CVS by listing it as a “Overweight.” The predicted price for CVS in the upcoming period, according to Barclays is $82 based on the research report published on October 10, 2024 of the current year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see CVS reach a price target of $85, previously predicting the price at $59. The rating they have provided for CVS stocks is “Buy” according to the report published on October 04th, 2024.
Robert W. Baird gave a rating of “Neutral” to CVS, setting the target price at $61 in the report published on May 30th of the current year.
CVS Trading at -1.53% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.31% of loss for the given period.
Volatility was left at 2.30%, however, over the last 30 days, the volatility rate increased by 2.34%, as shares surge +1.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.73% upper at present.
During the last 5 trading sessions, CVS fell by -12.55%, which changed the moving average for the period of 200-days by -27.95% in comparison to the 20-day moving average, which settled at $62.94. In addition, CVS Health Corp saw -25.47% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from LUDWIG EDWARD J, who purchase 1,000 shares at the price of $53.88 back on May 02 ’24. After this action, LUDWIG EDWARD J now owns 21,630 shares of CVS Health Corp, valued at $53,879 using the latest closing price.
Mahoney Michael F, the Director of CVS Health Corp, purchase 9,181 shares at $54.49 during a trade that took place back on May 02 ’24, which means that Mahoney Michael F is holding 9,356 shares at $500,294 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.14 for the gross margin
The net margin for CVS Health Corp stands at 0.02. The total capital return value is set at 0.07. Equity return is now at value 9.74, with 2.86 for asset returns.
Based on CVS Health Corp (CVS), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 0.91. The interest coverage ratio of the stock is 4.26.
Currently, EBITDA for the company is 18.44 billion with net debt to EBITDA at 4.29. When we switch over and look at the enterprise to sales, we see a ratio of 0.4. The receivables turnover for the company is 11.19for trailing twelve months and the total asset turnover is 1.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.86.
Conclusion
To put it simply, CVS Health Corp (CVS) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
